当前位置:主页 > 医学论文 > 药学论文 >

绣球菌多糖的分离纯化及其生物活性研究

发布时间:2019-01-23 18:43
【摘要】:水提取法提取绣球菌粗多糖,进行脱色和脱蛋白处理,分离纯化出多糖组分,测其单糖组成与红外光谱分析。结果表明D301T离子交换树脂脱色率达到了55.67%,是本试验中绣球菌多糖脱色的最佳树脂。从绣球菌多糖中主要分离出两个组分,蒸馏水洗脱的组分(SCPl)和0.1%NaCl洗脱的组分(SCP2),SCP1与SCP2单糖组成都主要为甘露糖(Man)、葡萄糖(Glu)、半乳糖(Gla)和岩藻糖(Fuc),其摩尔比分别为0.043:0.06:1.75:0.386和0.0554:1.656:0.1249:0.0201。红外光谱分析得到其都具有多糖特征结构。采用体外抗氧化试验与建立衰老模型、灌胃不同浓度绣球菌多糖(SCP)进行体内抗氧化试验。结果表明在体外试验中绣球菌多糖(SCP)及其组分SCP1和SCP2对羟自由基、ABTS和DPPH均有很好的清除效果,同时具有很好的还原力,且SCP2作用最为突出。体内试验中,绣球菌多糖能够降低小鼠体内的MDA同时提高SOD与CAT含量,抗氧化效果较好。采用MTT法、倒置显微镜观察法和荧光染色法研究绣球菌多糖不同组分抑制人肝癌HepG-2细胞增殖作用。结果表明绣球菌多糖组分对人肝癌HepG-2细胞有较好的抑制作用,SCP2的抑制作用最好,其作用24h与48h的抑制率分别为48.12%和56.45%,倒置显微镜法与荧光染色法都能观察到绣球菌多糖具有使人肝癌HepG-2细胞凋亡的作用。建造小鼠肿瘤模型,灌胃不同浓度绣球菌多糖(SCP),测定小鼠肿瘤大小、脾脏与胸腺指数和血清中TNF-a与TNF-P含量,对肿瘤组织进行石蜡切片观察,同时对小鼠进行生存试验。结果表明绣球菌多糖对S180实体瘤小鼠的肿瘤有明显的抑制作用,绣球菌多糖高剂量组最高抑制率达到50%;对小鼠脾脏与胸腺指数均有提高作用,且能增加小鼠体内TNF-a与TNF-p的含量;石蜡切片观察肿瘤组织发现其呈现凋亡病理学特征;绣球菌多糖对小鼠生存寿命有一定延长作用,高剂量组对小鼠寿命延长32.6%。本研究表明,绣球菌多糖具有较高的生物活性,其中纯化的多糖SCP1是以半乳糖为主的多糖。SCP2是以葡萄糖为主的多糖。以葡萄糖为主的SCP2组分生物活性最高,且具有良好抗氧化功效,在体外对人肝癌HepG-2细胞的抑制作用也最好。绣球菌多糖在体内能抑制S180实体瘤小鼠的肿瘤和延长肿瘤小鼠生存寿命的抗肿瘤与作用抗氧化功效,是很值得重视和开发的药用真菌。
[Abstract]:The polysaccharide was extracted by water extraction, decolorized and deproteinized. The polysaccharide components were separated and purified. The monosaccharide composition of the polysaccharide was analyzed by infrared spectroscopy. The results showed that the decolorization rate of D301T ion exchange resin was 55.67, which was the best resin for decolorizing hydrangea polysaccharide. Two main components were isolated from the polysaccharides of Hydrangea, distilled water eluting components (SCPl) and 0.1%NaCl elution components (SCP2), and SCP1 and SCP2 monosaccharide groups in Chengdu were mainly mannose (Man), glucose (Glu),. The molar ratios of galactose (Gla) and fucose (Fuc), are 0.043: 0.06: 1.75: 0.386 and 0.0554: 1.656: 0.1249: 0.0201, respectively. Infrared spectrum analysis showed that all of them had the characteristic structure of polysaccharides. Antioxidation test in vitro and establishment of aging model were carried out in vivo with different concentrations of Hydrangea polysaccharide (SCP). The results showed that (SCP), its components SCP1 and SCP2 had good scavenging effect on hydroxyl radical, ABTS and DPPH in vitro, and had good reducing power, and SCP2 had the most prominent effect. In vivo experiment, Hydrangea polysaccharide could decrease MDA and increase the contents of SOD and CAT in mice, and the antioxidant effect was better. The effects of different components of hydrangea polysaccharides on the proliferation of human hepatoma HepG-2 cells were studied by MTT, inverted microscope and fluorescence staining. The results showed that the polysaccharides of Hydrangea had a better inhibitory effect on human hepatoma HepG-2 cells, and SCP2 had the best inhibitory effect. The inhibitory rates of SCP2 at 24h and 48h were 48.12% and 56.45%, respectively. It was observed by inverted microscope and fluorescence staining that Hydrangea polysaccharide could induce apoptosis of human hepatoma HepG-2 cells. The tumor model was established in mice. The tumor size, spleen and thymus index, TNF-a and TNF-P content in serum were measured by (SCP), with different concentrations of hydrangea polysaccharide. The tumor tissue was observed by paraffin section. At the same time, the survival test of mice was carried out. The results showed that Hydrangea polysaccharide had obvious inhibitory effect on tumor of S180 solid tumor mice, and the highest inhibitory rate of Hydrangea polysaccharide group was 50%. The indexes of spleen and thymus were increased, and the contents of TNF-a and TNF-p in mice were increased, and the pathological characteristics of apoptosis were found by paraffin section. Hydrangea polysaccharide could prolong the life span of mice to a certain extent, and the life span of mice in high dose group was increased by 32.6%. The results showed that the polysaccharides of Hydrangea had high bioactivity. The purified polysaccharide SCP1 was galactose and SCP2 was glucose. The SCP2 component with glucose as the main component has the highest bioactivity and has good antioxidant activity. It also has the best inhibitory effect on human hepatoma HepG-2 cells in vitro. Hydrangea polysaccharide can inhibit the tumor of S180 solid tumor mice in vivo and prolong the survival life of tumor mice. It is worthy of attention and development of medicinal fungi.
【学位授予单位】:福建师范大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R915

【相似文献】

相关期刊论文 前10条

1 刘菊香;贾建波;;木蹄层孔菌多糖分离纯化及其结构初步鉴定[J];食品科学;2009年24期

2 李呼伦,程志,张凤民,凌虹,曲章文,,李绍贤;毛柄金钱菌多糖抗肿瘤作用的研究[J];哈尔滨医科大学学报;1994年04期

3 赵弋清;罗霞;刘高阳;杨志荣;;亮菌多糖对S_(180)荷瘤小鼠免疫功能的研究[J];免疫学杂志;2006年S1期

4 张平;宋群亮;李绍平;屈成明;黄赵刚;夏泉;刘刚;;正交实验优选亮菌多糖的提取工艺[J];中国药师;2007年04期

5 高天舒,吴纪经,吴英华;酵母菌多糖对肉用仔鸡肠道菌群的影响[J];中国实验动物学杂志;1997年04期

6 蔡凤;解彦刚;黄纯;樊一桥;;亮菌多糖的分离纯化及体内抗肿瘤活性研究[J];基因组学与应用生物学;2013年06期

7 陈福禄,谢宝贵,郑金贵;药用菌多糖的药用功能与展望[J];中国药学杂志;2005年04期

8 周莹,沈萍萍,彭士明,华子春;红栓菌多糖的免疫增强效应研究[J];药物生物技术;2002年03期

9 邓岚,马耀辉,苏任,陈爱群;虫草菌多糖的部分理化性质研究[J];云南大学学报(自然科学版);2003年S1期

10 梁秀宇;王强;;药用菌多糖联合中药治疗银屑病疗效观察[J];中国中西医结合皮肤性病学杂志;2009年05期

相关会议论文 前4条

1 任惠霞;张平;程钢;夏泉;黄赵刚;;亮菌多糖的水提工艺[A];中国药理学会第十一次全国学术会议专刊[C];2011年

2 孙明立;魏敏杰;金万宝;杜娃;王爽;赵琳;赵海山;姚维凡;;卡介菌多糖-核酸对二硝基氟苯诱导的接触性皮炎的治疗作用及机制[A];两岸三地药理学与临床药理学术会议论文集[C];2008年

3 罗霞;赵弋清;陈东辉;刘高阳;许晓燕;杨志荣;;亮菌多糖对S_(180)荷瘤小鼠免疫功能的研究[A];2006中国微生物学会第九次全国会员代表大会暨学术年会论文摘要集[C];2006年

4 刘玉红;王凤山;;茶麓子木层孔菌多糖的结构和生物活性研究[A];2007年全国生化与生物技术药物学术年会论文集[C];2007年

相关博士学位论文 前1条

1 王凤芹;Z0206细菌多糖的结构分析及其对小鼠糖脂代谢的影响研究[D];浙江大学;2013年

相关硕士学位论文 前10条

1 洪小君;绣球菌多糖提取、分离纯化及生物活性研究[D];福建农林大学;2015年

2 张传能;绣球菌多糖的分离纯化及其生物活性研究[D];福建师范大学;2015年

3 赵弋清;亮菌多糖对肿瘤免疫效应机制的研究[D];四川大学;2006年

4 王雪冰;云南野生虎掌菌多糖的提取及其抗氧化研究[D];昆明理工大学;2011年

5 陈洁;木蹄层孔菌多糖的提取工艺及免疫活性研究[D];南方医科大学;2011年

6 岳金玫;攀枝花块菌多糖的提取、纯化及抗氧化活性研究[D];四川农业大学;2012年

7 高婷;亮菌发酵工艺、亮菌多糖及药效学研究[D];四川大学;2005年

8 吴礼萍;鸭胚蛋营养分析评价及与牛肝菌多糖配伍的功能性研究[D];山东农业大学;2009年

9 赵云霞;鸡枞菌多糖对小鼠急性酒精肝损伤保护作用的研究[D];南京师范大学;2014年

10 孔庆龙;印度块菌多糖的分离纯化、结构表征及抗氧化性研究[D];昆明理工大学;2013年



本文编号:2414093

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2414093.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户aeada***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com